BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29494512)

  • 1. Selenium and Selenoproteins in Gut Inflammation-A Review.
    Nettleford SK; Prabhu KS
    Antioxidants (Basel); 2018 Mar; 7(3):. PubMed ID: 29494512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium and inflammatory bowel disease.
    Kudva AK; Shay AE; Prabhu KS
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G71-7. PubMed ID: 26045617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγ.
    Li MY; Zhang ZH; Wang Z; Zuo HX; Wang JY; Xing Y; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    Pharmacol Res; 2019 Sep; 147():104355. PubMed ID: 31386886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium Deficiency Deteriorate the Inflammation of S. aureus Infection via Regulating NF-κB and PPAR-γ in Mammary Gland of Mice.
    Gao X; Zhang Z; Li Y; Hu X; Shen P; Fu Y; Cao Y; Zhang N
    Biol Trace Elem Res; 2016 Jul; 172(1):140-147. PubMed ID: 26554949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selenium-lead interaction on the gene expression of inflammatory factors and selenoproteins in chicken neutrophils.
    Li X; Xing M; Chen M; Zhao J; Fan R; Zhao X; Cao C; Yang J; Zhang Z; Xu S
    Ecotoxicol Environ Saf; 2017 May; 139():447-453. PubMed ID: 28213321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium-Containing Phycocyanin from Se-Enriched Spirulina platensis Reduces Inflammation in Dextran Sulfate Sodium-Induced Colitis by Inhibiting NF-κB Activation.
    Zhu C; Ling Q; Cai Z; Wang Y; Zhang Y; Hoffmann PR; Zheng W; Zhou T; Huang Z
    J Agric Food Chem; 2016 Jun; 64(24):5060-70. PubMed ID: 27223481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting summary: Signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A.
    Plevy S; Mayer L
    Inflamm Bowel Dis; 2003 Jan; 9(1):28-33. PubMed ID: 12656135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium and selenoproteins in inflammatory bowel diseases and experimental colitis.
    Speckmann B; Steinbrenner H
    Inflamm Bowel Dis; 2014 Jun; 20(6):1110-9. PubMed ID: 24694793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
    Venkataraman B; Ojha S; Belur PD; Bhongade B; Raj V; Collin PD; Adrian TE; Subramanya SB
    Phytother Res; 2020 Jul; 34(7):1530-1549. PubMed ID: 32009281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
    Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
    J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
    Mukohda M; Lu KT; Guo DF; Wu J; Keen HL; Liu X; Ketsawatsomkron P; Stump M; Rahmouni K; Quelle FW; Sigmund CD
    Hypertension; 2017 Jul; 70(1):174-182. PubMed ID: 28507170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.
    Decara J; Rivera P; López-Gambero AJ; Serrano A; Pavón FJ; Baixeras E; Rodríguez de Fonseca F; Suárez J
    Front Pharmacol; 2020; 11():730. PubMed ID: 32536865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.
    Lim HA; Lee EK; Kim JM; Park MH; Kim DH; Choi YJ; Ha YM; Yoon JH; Choi JS; Yu BP; Chung HY
    Biogerontology; 2012 Apr; 13(2):133-45. PubMed ID: 22033706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
    Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
    Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium and inflammation: underlying anti-inflammatory mechanisms.
    Duntas LH
    Horm Metab Res; 2009 Jun; 41(6):443-7. PubMed ID: 19418416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases.
    Zaidi D; Wine E
    Front Pediatr; 2018; 6():317. PubMed ID: 30425977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.